Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000277241 | SCV000341839 | uncertain significance | not provided | 2016-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000277241 | SCV001006053 | benign | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374475 | SCV002667558 | benign | Inborn genetic diseases | 2019-05-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000277241 | SCV004163854 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | HOXA1: BP4, BP7 |